Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Enhancing Clinical Trial Selection for Cancer Patients Using Large Language Models
0
Zitationen
2
Autoren
2026
Jahr
Abstract
This work demonstrates the feasibility of using proprietary LLMs such as GPT 4.0 and Gemini 2.0 "off the shelf" with both limited LLM fine-tuning and limited patient information to evaluate clinical trial eligibility.
Ähnliche Arbeiten
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 · 30.894 Zit.
A global reference for human genetic variation
2015 · 19.446 Zit.
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 · 18.063 Zit.
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
2010 · 15.245 Zit.
A method and server for predicting damaging missense mutations
2010 · 13.438 Zit.